A pharmaceutical composition for the prevention and treatment of human cognitive deficit includes oleuropein or its derivatives and glutathione conjugated with a carboxylic acid. The carboxylic acid component of the glutathione-carboxylic acid conjugate is any saturated or unsaturated aliphatic carboxylic acid, containing from 2 to 22 carbon atoms.
